ABBV
Abbvie Inc
Price:  
266.69 
USD
Volume:  
4,413,371.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Abbvie Relative Valuation

-58.3%
Upside

As of 2026-10-07, the Relative Valuation of Abbvie Inc (ABBV) is 111.21 USD. This relative valuation is based on P/E multiples. With the latest stock price at 266.69 USD, the upside of Abbvie Inc based on Relative Valuation is -58.3%.

The range of the Relative Valuation is 95.44 - 169.36 USD.

Range Selected
Trailing P/E multiples 29.9x - 47.4x 35.0x
Forward P/E multiples 24.4x - 26.8x 24.9x
Fair Price 95.44 - 169.36 111.21
Upside -64.2% - -36.5% -58.3%
266.69 USD
Stock Price
111.21 USD
Fair Price

Abbvie Relative Valuation - Historical P/E Data

Date P/E
2026-10-06 74.67
2026-10-05 74.41
2026-10-02 73.59
2026-10-01 72.78
2026-09-30 73.24
2026-09-29 73.72
2026-09-28 74.56
2026-09-25 74.01
2026-09-24 74.23
2026-09-23 74.22
2026-09-22 74.26
2026-09-21 74.05
2026-09-18 73.91
2026-09-17 73.93
2026-09-16 73.50
2026-09-15 73.65
2026-09-14 73.30
2026-09-11 71.99
2026-09-10 71.40
2026-09-09 70.25
2026-09-08 69.66
2026-09-04 71.81
2026-09-03 72.86
2026-09-02 73.28
2026-09-01 72.80
2026-08-31 71.80
2026-08-28 71.53
2026-08-27 72.28
2026-08-26 73.61
2026-08-25 74.42
2026-08-24 74.07
2026-08-21 74.19
2026-08-20 73.31
2026-08-19 74.47
2026-08-18 72.50
2026-08-17 70.09
2026-08-14 69.85
2026-08-13 70.23
2026-08-12 69.65
2026-08-11 70.02
2026-08-10 69.43
2026-08-07 68.89
2026-08-06 68.28
2026-08-05 68.94
2026-08-04 68.26
2026-08-03 68.63
2026-07-31 70.26
2026-07-30 72.07
2026-07-29 73.72
2026-07-28 73.70